Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Debt to Equity (2021 - 2024)

Standard Biotools (LAB) has disclosed Debt to Equity for 7 consecutive years, with $0.11 as the latest value for Q2 2024.

  • Quarterly Debt to Equity rose 217.14% to $0.11 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $0.11 through Jun 2024, up 217.14% year-over-year, with the annual reading at -$0.06 for FY2023, 43.5% up from the prior year.
  • Debt to Equity for Q2 2024 was $0.11 at Standard Biotools, up from -$0.06 in the prior quarter.
  • The five-year high for Debt to Equity was $0.46 in Q1 2022, with the low at -$0.27 in Q2 2022.
  • Average Debt to Equity over 4 years is -$0.0, with a median of -$0.07 recorded in 2023.
  • The sharpest move saw Debt to Equity tumbled 261.78% in 2022, then surged 217.14% in 2024.
  • Over 4 years, Debt to Equity stood at $0.18 in 2021, then plummeted by 156.34% to -$0.1 in 2022, then soared by 43.5% to -$0.06 in 2023, then surged by 288.91% to $0.11 in 2024.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.11, -$0.06, and -$0.07 for Q2 2024, Q4 2023, and Q3 2023 respectively.